Table 2.
Events | Apixaban | Warfarin | Source |
---|---|---|---|
Ischemic stroke risk by CHADS2 | [15] | ||
Mean | 0,962 | 1,064 | |
CHADS2 score 0 | 0,521 | 0,458 | |
CHADS2 score 1 | 0,521 | 0,458 | |
CHADS2 score 2 | 0,950 | 0,934 | |
CHADS2 score 3 | 1,534 | 1,944 | |
CHADS2 score 4 | 1,534 | 1,944 | |
CHADS2 score 5 | 1,534 | 1,944 | |
CHADS2 score 6 | 1,534 | 1,944 | |
Systemic embolism | 0.090 | 0.100 | [12] |
Hemorrhagic stroke and Intracranial Hemorrhage | 0.330 | 0.800 | [12] |
Other major bleeding | 1.790 | 2.270 | [12] |
Clinically Relevant Non-Major Bleeding | 2.083 | 2.995 | [15] |
Myocardial Infarction | 0,530 | 0,610 | [12] |
Other hospitalizations due to cardiovascular disease | 10.460 | 10.460 | [15] |
Recurrent ischemic stroke | 4.103 | 4.103 | [43] |
Recurrent hemorrhagic stroke | 3.00 | 3.00 | [43] |